493 related articles for article (PubMed ID: 27373195)
21. Clinicopathologic Analysis of Proton Pump Inhibitor-Responsive Esophageal Eosinophilia in Korean Patients.
Jung DH; Yun GW; Lee YJ; Jo Y; Park H
Gut Liver; 2016 Jan; 10(1):37-41. PubMed ID: 25963082
[TBL] [Abstract][Full Text] [Related]
22. Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation.
Wen T; Dellon ES; Moawad FJ; Furuta GT; Aceves SS; Rothenberg ME
J Allergy Clin Immunol; 2015 Jan; 135(1):187-97. PubMed ID: 25441638
[TBL] [Abstract][Full Text] [Related]
23. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.
Molina-Infante J; Ferrando-Lamana L; Ripoll C; Hernandez-Alonso M; Mateos JM; Fernandez-Bermejo M; Dueñas C; Fernandez-Gonzalez N; Quintana EM; Gonzalez-Nuñez MA
Clin Gastroenterol Hepatol; 2011 Feb; 9(2):110-7. PubMed ID: 20920599
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease.
Ribolsi M; Cicala M; Zentilin P; Neri M; Mauro A; Efthymakis K; Petitti T; Savarino V; Penagini R
Aliment Pharmacol Ther; 2018 Nov; 48(10):1074-1081. PubMed ID: 30294924
[TBL] [Abstract][Full Text] [Related]
25. Proton-pump inhibitor-responsive esophageal eosinophilia.
Molina-Infante J; Katzka DA
Curr Opin Gastroenterol; 2014 Jul; 30(4):428-33. PubMed ID: 24837227
[TBL] [Abstract][Full Text] [Related]
26. Temporal trends in the relative prevalence of dysphagia etiologies from 1999-2009.
Kidambi T; Toto E; Ho N; Taft T; Hirano I
World J Gastroenterol; 2012 Aug; 18(32):4335-41. PubMed ID: 22969196
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and treatment of eosinophilic esophagitis in clinical practice.
Abe Y; Sasaki Y; Yagi M; Yaoita T; Nishise S; Ueno Y
Clin J Gastroenterol; 2017 Apr; 10(2):87-102. PubMed ID: 28247277
[TBL] [Abstract][Full Text] [Related]
28. Identification of clinical and laboratory markers for predicting eosinophilic esophagitis in adults.
von Arnim U; Wex T; Röhl FW; Neumann H; Küster D; Weigt J; Mönkemüller K; Malfertheiner P
Digestion; 2011; 84(4):323-7. PubMed ID: 22075653
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness model of endoscopic biopsy for eosinophilic esophagitis in patients with refractory GERD.
Miller SM; Goldstein JL; Gerson LB
Am J Gastroenterol; 2011 Aug; 106(8):1439-45. PubMed ID: 21448144
[TBL] [Abstract][Full Text] [Related]
30. Comparison of clinical features in patients with eosinophilic esophagitis living in an urban and rural environment.
Lee YJ; Redd M; Bayman L; Frederickson N; Valestin J; Schey R
Dis Esophagus; 2015 Jan; 28(1):19-24. PubMed ID: 24382218
[TBL] [Abstract][Full Text] [Related]
31. Proton pump inhibitors for eosinophilic oesophagitis.
Cheng E
Curr Opin Gastroenterol; 2013 Jul; 29(4):416-20. PubMed ID: 23449027
[TBL] [Abstract][Full Text] [Related]
32. [Insufficient symptom control under long-term treatment with PPI in GERD - fact or fiction?].
Labenz J; Labenz G; Stephan D; Willeke F;
MMW Fortschr Med; 2016 May; 158 Suppl 4():7-11. PubMed ID: 27221555
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and characteristics of acid gastro-oesophageal reflux disease in Jackhammer oesophagus.
Mallet AL; Ropert A; Bouguen G; Siproudhis L; Boutroux D; Bretagne JF; Brochard C
Dig Liver Dis; 2016 Oct; 48(10):1136-41. PubMed ID: 27453169
[TBL] [Abstract][Full Text] [Related]
34. The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor.
Vazquez-Elizondo G; Ngamruengphong S; Khrisna M; Devault KR; Talley NJ; Achem SR
Aliment Pharmacol Ther; 2013 Nov; 38(10):1312-9. PubMed ID: 24117619
[TBL] [Abstract][Full Text] [Related]
35. PPI-responsive esophageal eosinophilia cannot be distinguished from eosinophilic esophagitis by endoscopic signs.
Warners MJ; van Rhijn BD; Curvers WL; Smout AJ; Bredenoord AJ
Eur J Gastroenterol Hepatol; 2015 May; 27(5):506-11. PubMed ID: 25822858
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of step-down therapy in adult patients with proton pump inhibitor-responsive oesophageal eosinophilia.
Gómez-Torrijos E; García-Rodríguez R; Castro-Jiménez A; Rodríguez-Sanchez J; Méndez Díaz Y; Molina-Infante J
Aliment Pharmacol Ther; 2016 Feb; 43(4):534-40. PubMed ID: 26662868
[TBL] [Abstract][Full Text] [Related]
37. Validation of the GerdQ questionnaire for the diagnosis of gastro-oesophageal reflux disease.
Jonasson C; Wernersson B; Hoff DA; Hatlebakk JG
Aliment Pharmacol Ther; 2013 Mar; 37(5):564-72. PubMed ID: 23289763
[TBL] [Abstract][Full Text] [Related]
38. Predictors of proton pump inhibitor failure in non-erosive reflux disease: A study with impedance-pH monitoring and high-resolution manometry.
Shi Y; Tan N; Zhang N; Xiong L; Peng S; Lin J; Chen M; Xiao Y
Neurogastroenterol Motil; 2016 May; 28(5):674-9. PubMed ID: 26768192
[TBL] [Abstract][Full Text] [Related]
39. Proton pump inhibitor responsive esophageal eosinophilia, a distinct disease entity?
Munday W; Zhang X
World J Gastroenterol; 2014 Aug; 20(30):10419-24. PubMed ID: 25132757
[TBL] [Abstract][Full Text] [Related]
40. Eosinophilic esophagitis in Japan: Focus on response to acid suppressive therapy.
Ishimura N; Kinoshita Y
J Gastroenterol Hepatol; 2018 May; 33(5):1016-1022. PubMed ID: 29278655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
